# Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

> **NCT07461948** · PHASE3 · RECRUITING · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 15 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Chemical Exchange Saturation Transfer Magnetic Resonance Imaging
- **PROCEDURE:** Diffusion-Relaxation Correlation Spectrum Imaging
- **OTHER:** Electronic Health Record Review
- **DRUG:** Ferumoxytol
- **RADIATION:** Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT07461948
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-27
- **Primary completion:** 2028-10-27
- **Final completion:** 2028-10-27
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07461948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07461948, "Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07461948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*